Published on 9 Feb 2023 on Simply Wall St. via Yahoo Finance
Every investor in Vera Therapeutics, Inc. (NASDAQ:VERA) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 35% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.
Let's delve deeper into each type of owner of Vera Therapeutics, beginning with the chart below.